NeuroproteXeon have completed a distribution agreement with Linde AG for XENEXTM (xenon by inhalation) for Post Cardiac Arrest Syndrome (PCAS) for the European Union plus United Kingdom, Switzerland, Norway and Iceland.
If you already subscribe, please sign-in now
To access hundreds of features, subscribe today! At a time when the world is forced to go digital more than ever before just to stay connected, discover the in-depth content our subscribers receive every month by subscribing to gasworld.
Don’t just stay connected, stay at the forefront – join gasworld and become a subscriber to access all of our must-read content online from just $310.